tetano
Editor, Senior Moderator
J Cardiovasc Magn Reson
. 2022 Dec 21;24(1):73.
doi: 10.1186/s12968-022-00907-8.
Utilization of cardiovascular magnetic resonance (CMR) imaging for resumption of athletic activities following COVID-19 infection: an expert consensus document on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention (CVRI) Leadership and endorsed by the Society for Cardiovascular Magnetic Resonance (SCMR)
Frederick L Ruberg[SUP] 1 [/SUP], Aaron L Baggish[SUP] 2 [/SUP], Allison G Hays[SUP] 3 [/SUP], Michael Jerosch-Herold[SUP] 4 [/SUP], Jiwon Kim[SUP] 5 [/SUP], Karen G Ordovas[SUP] 6 [/SUP], Gautham Reddy[SUP] 6 [/SUP], Chetan Shenoy[SUP] 7 [/SUP], Jonathan W Weinsaft[SUP] 5 [/SUP], Pamela K Woodard[SUP] 8 [/SUP]
Affiliations
Abstract
The global pandemic of coronavirus disease 2019 (COVID-19) caused by infection with severe acute respiratory suyndrome coronavirus 2 (SARS-CoV-2) is now entering its 4th year with little evidence of abatement. As of December 2022, the World Health Organization Coronavirus (COVID-19) Dashboard reported 643 million cumulative confirmed cases of COVID-19 worldwide and 98 million in the United States alone as the country with the highest number of cases. While pneumonia with lung injury has been the manifestation of COVID-19 principally responsible for morbidity and mortality, myocardial inflammation and systolic dysfunction though uncommon are well-recognized features that also associate with adverse prognosis. Given the broad swath of the population infected with COVID-19, the large number of affected professional, collegiate, and amateur athletes raises concern regarding the safe resumption of athletic activity (return to play, RTP) following resolution of infection. A variety of different testing combinations that leverage the electrocardiogram, echocardiography, circulating cardiac biomarkers, and cardiovascular magnetic resonance (CMR) imaging have been proposed and implemented to mitigate risk. CMR in particular affords high sensitivity for myocarditis but has been employed and interpreted non-uniformly in the context of COVID-19 thereby raising uncertainty as to the generalizability and clinical relevance of findings with respect to RTP. This consensus document synthesizes available evidence to contextualize the appropriate utilization of CMR in the RTP assessment of athletes with prior COVID-19 infection to facilitate informed, evidence-based decisions, while identifying knowledge gaps that merit further investigation.
Keywords: Athlete; COVID-19; Magnetic resonance imaging; Myocarditis.
. 2022 Dec 21;24(1):73.
doi: 10.1186/s12968-022-00907-8.
Utilization of cardiovascular magnetic resonance (CMR) imaging for resumption of athletic activities following COVID-19 infection: an expert consensus document on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention (CVRI) Leadership and endorsed by the Society for Cardiovascular Magnetic Resonance (SCMR)
Frederick L Ruberg[SUP] 1 [/SUP], Aaron L Baggish[SUP] 2 [/SUP], Allison G Hays[SUP] 3 [/SUP], Michael Jerosch-Herold[SUP] 4 [/SUP], Jiwon Kim[SUP] 5 [/SUP], Karen G Ordovas[SUP] 6 [/SUP], Gautham Reddy[SUP] 6 [/SUP], Chetan Shenoy[SUP] 7 [/SUP], Jonathan W Weinsaft[SUP] 5 [/SUP], Pamela K Woodard[SUP] 8 [/SUP]
Affiliations
- PMID: 36539786
- DOI: 10.1186/s12968-022-00907-8
Abstract
The global pandemic of coronavirus disease 2019 (COVID-19) caused by infection with severe acute respiratory suyndrome coronavirus 2 (SARS-CoV-2) is now entering its 4th year with little evidence of abatement. As of December 2022, the World Health Organization Coronavirus (COVID-19) Dashboard reported 643 million cumulative confirmed cases of COVID-19 worldwide and 98 million in the United States alone as the country with the highest number of cases. While pneumonia with lung injury has been the manifestation of COVID-19 principally responsible for morbidity and mortality, myocardial inflammation and systolic dysfunction though uncommon are well-recognized features that also associate with adverse prognosis. Given the broad swath of the population infected with COVID-19, the large number of affected professional, collegiate, and amateur athletes raises concern regarding the safe resumption of athletic activity (return to play, RTP) following resolution of infection. A variety of different testing combinations that leverage the electrocardiogram, echocardiography, circulating cardiac biomarkers, and cardiovascular magnetic resonance (CMR) imaging have been proposed and implemented to mitigate risk. CMR in particular affords high sensitivity for myocarditis but has been employed and interpreted non-uniformly in the context of COVID-19 thereby raising uncertainty as to the generalizability and clinical relevance of findings with respect to RTP. This consensus document synthesizes available evidence to contextualize the appropriate utilization of CMR in the RTP assessment of athletes with prior COVID-19 infection to facilitate informed, evidence-based decisions, while identifying knowledge gaps that merit further investigation.
Keywords: Athlete; COVID-19; Magnetic resonance imaging; Myocarditis.